• The S&P ASX 200 was down 0.73% in August with mid caps and small caps down 1.3% for the month
  • Eight of 11 sectors down in August with consumer discretionary leading winners and utilities the laggards
  • Tech stock 4DS Memory rises more than 360% in August after announcing a major breakthrough

Australian markets fell in August. Australian large caps were down 0.7% for the month, reducing YTD gains. Mid- caps and small-caps lagged blue chips, with both the S&P/ASX MidCap 50 and the S&P/ASX Small Ordinaries down 1.3% in August.

While the S&P ASX MidCap 50 and the S&P ASX Small Ordinaries are up YTD, the S&P ASX Emerging Companies indices still has some catch-up to do with four months left for 2023, according to S&P Dow Jones Indices.

ASX August 2023
Source: S&P Dow Jones Indices

 

China slowdown fears prey on markets

Several headwinds faced global markets during August with the economic slowdown in China topping the list.  Key economic data points coming out of China in August spooked markets with a rally that was expected in spending after prolonged Covid-19 lockdowns in the world’s second largest economy failing to eventuate.

A big slowdown in China’s property market, which accounts for ~25% of the economy,  saw one of the country’s largest developers Country Garden posting a net loss between January and June of 48.9 billion yuan ($6.72 billion) and posing a default risk.

Furthermore, China’s second-largest property developer, heavily indebted Evergrande, filed for US bankruptcy protection in August as part of one of the largest debt restructurings.

There was mixed news coming out of the world’s largest economy in August as the US Federal Reserve continues to work towards a soft landing as it aims to bring inflation back to its 2% target.

The US unemployment rate increased to 3.8% in August, up from the previous 3.5% in July. Employers expanded their payrolls by 187,000 workers in the past month, which was above the 170,000 forecasted.

“Today’s report is consistent with an economy that is transitioning to steady and stable growth, an important and necessary deceleration that is helping to ease price pressures while maintaining a strong labor market,” The White House said.

At a key speech at the annual economic symposium hosted by the Federal Reserve Bank of Kansas City in Jackson Hole, Wyoming Fed Reserve chair Jerome Powell maintained a hawkish stand.  The US consumer price index rose 3.2% from a year ago in July, slightly below expectations.

“Although inflation has moved down from its peak – a welcome development – it remains too high,” Powell said in his speech.

“We are prepared to raise rates further if appropriate, and intend to hold policy at a restrictive level until we are confident that inflation is moving sustainably down toward our objective.”

In Australia inflation slowed to a 17-month low, a signal that interest rate hikes might be coming to an end. Australian Bureau of Statistics data released in August showed the monthly consumer price index (CPI) rose 4.9% in the year to July, down from 5.4% in June and under market forecasts of 5.2%.

 

Equity factors in red, consumer discretionary & fixed income win out

All reported Australian equity factor indices closed in the red for August, with S&P reporting growth as the most successful in limiting its losses, down just 0.4%. At the other end of the spectrum, Enhanced Value lost 3.1%.

ASX August 2023
Source: S&P Dow Jones Indices

Eight of the 11 sectors finished in the red in August. The S&P/ASX 200 Consumer Discretionary was the best performing sector, up 5.74%, while Utilities lagged, down 3.85%.

Source: S&P Dow Jones Indices

Fixed income was one of the big winners in August, extending gains for the quarter and YTD.

READ: Are bonds cheap now that inflation has peaked? Here’s what an expert says, and a quick explainer

Source: S&P Dow Jones Indices

 

Here are the 50 best performing ASX stocks for August:

Scroll or swipe to reveal table. Click headings to sort.

CODE COMPANY LAST SHARE PRICE AUGUST RETURN % MARKET CAP
4DS 4Ds Memory Limited 0.1475 361% $276,605,306
RDN Raiden Resources Ltd 0.03 300% $49,326,454
ECG Ecargo Holdings 0.038 171% $28,301,500
VMM Viridis Mining 0.6 140% $16,250,346
LLI Loyal Lithium Ltd 0.735 130% $52,527,205
WC8 Wildcat Resources 0.375 127% $242,946,907
IGN Ignite Ltd 0.08 90% $7,166,574
NMR Native Mineral Resources 0.056 87% $7,406,459
BRX Belararox 0.485 87% $24,329,089
RLG Roolife Group Ltd 0.013 86% $8,646,698
INP Incentiapay Ltd 0.011 83% $13,915,700
BEX Bikeexchange Ltd 0.009 80% $9,513,201
IEC Intra Energy Corp 0.007 75% $9,724,690
RHK Red Hawk Mining Ltd 0.785 74% $126,636,433
OKJ Oakajee Corp Ltd 0.026 73% $2,194,705
HLA Healthia Limited 1.7425 72% $136,687,178
STP Step One Limited 0.58 66% $101,937,160
FRE Firebrick Pharma 0.32 64% $35,189,402
KNB Koonenberry Gold 0.054 64% $4,090,848
OAR OAR Resources Ltd 0.0065 63% $15,678,814
ACM Australian Critical Minerals 0.3225 61% $8,473,406
AW1 American West Metals 0.295 59% $104,554,313
LDX Lumos Diagnostics 0.1 59% $48,778,719
ARV Artemis Resources 0.028 56% $45,527,633
GCX GCX Metals Limited 0.043 54% $8,360,041
RTH Ras Tech 0.76 54% $37,276,040
VEE Veem Ltd 0.65 53% $88,217,644
AD8 Audinate Group Ltd 13.95 53% $1,081,842,397
FTL Firetail Resources 0.125 52% $12,031,250
OAK Oakridge 0.12 52% $2,063,481
EML EML Payments Ltd 1.145 51% $402,032,939
KKO Kinetiko Energy Ltd 0.12 50% $89,764,805
MPG Many Peaks Gold 0.3 50% $11,276,090
ROC RocketBoots 0.12 50% $3,579,235
BVS Bravura Solution Ltd 0.76 49% $345,232,582
EL8 Elevate Uranium Ltd 0.445 48% $122,260,221
NGY Nuenergy Gas Ltd 0.04 48% $57,757,264
PPG Pro-Pac Packaging 0.31 48% $56,323,190
LU7 Lithium Universe Ltd 0.044 47% $18,260,529
IMR Imricor Med Sys 0.645 47% $98,842,890
BOT Botanix Pharma Ltd 0.19 46% $284,239,363
ERG Eneco Refresh Ltd 0.019 46% $5,174,809
MIL Millennium Grp Ltd 0.365 46% $16,978,773
BIO Biome Australia Ltd 0.14 46% $21,118,890
FME Future Metals NL 0.048 45% $19,007,386
3DA Amaero International 0.195 44% $81,284,817
MBK Metal Bank Ltd 0.049 44% $13,547,790
AGE Alligator Energy 0.046 44% $148,766,352
BDX Bcal Diagnostics 0.1 43% $21,323,269
AEE Aura Energy 0.275 41% $158,163,006
Wordpress Table Plugin

 

4DS Memory (ASX:4DS) topped the winners list in August, up more than 360% after announcing a breakthrough, where it  it had successfully incorporated its ReRAM memory cells into the imec megabit array.

The company has validated that 4DS Interface Switching ReRAM technology is transferable from fab to fab, and demonstrated a fully functional megabit array with 4DS Interface Switching ReRAM memory cells.

“The results obtained are significantly better than the Board and management team at 4DS were expecting,”  4DS said in its announcement.

Also up more than 300% in August was Raiden Resources (ASX:RDN), which last week announced it’s managed to secure firm commitments to raise another $6 million in funding via a share placement to professional, sophisticated, and institutional investors.

The lithium hunter says it will use the funds chiefly to progress exploration work and drilling at its portfolio of lithium projects located in the Pilbara region of Western Australia. That, and to potentially upgrade its 85% interest in lithium-gold acreage held by Arrow Minerals (ASX:AMD) to 100% interest.

 

Here are the 50 worst performing ASX stocks for August:

Scroll or swipe to reveal table. Click headings to sort.

CODE COMPANY LAST SHARE PRICE AUGUST RETURN % MARKET CAP
ELE Elmore Ltd 0.003 -63% $4,198,151
CLA Celsius Resource Ltd 0.01 -58% $24,706,568
BAT Battery Minerals Ltd 0.056 -57% $7,654,688
MSB Mesoblast Limited 0.515 -55% $370,463,195
SIX Sprintex Ltd 0.019 -55% $6,792,383
3DP Pointerra Limited 0.093 -55% $67,621,057
SPL Starpharma Holdings 0.1475 -55% $57,469,031
8VI 8Vi Holdings Limited 0.105 -54% $5,029,371
ANO Advance Zinctek Ltd 0.815 -52% $68,674,891
ICG Inca Minerals Ltd 0.02 -51% $9,215,190
CGO CPT Global Limited 0.13 -51% $9,007,933
AVW Avira Resources Ltd 0.001 -50% $3,200,685
GGX Gas2Grid Limited 0.001 -50% $4,077,102
KEY KEY Petroleum 0.001 -50% $2,951,892
SPT Splitit 0.038 -47% $23,237,929
VTM Victory Metals Ltd 0.21 -47% $16,584,429
GCM Green Critical Min 0.008 -47% $8,957,429
NSM Northstaw 0.048 -47% $7,207,620
NWF Newfield Resources 0.15 -46% $115,330,631
NYR Nyrada Inc. 0.027 -46% $4,056,226
AMM Armada Metals 0.022 -42% $1,508,497
BET Betmakers Tech Group 0.105 -42% $103,789,576
ME1 Melodiol Glb Health 0.007 -42% $20,256,243
GBE Globe Metals & Mining 0.038 -41% $19,763,979
TRE Toubani Resources 0.115 -41% $13,285,870
FRS Forrestania Resources 0.062 -41% $5,773,589
BIR BIR Financial Ltd 0.044 -41% $13,212,989
CXO Core Lithium 0.395 -40% $843,406,718
CHN Chalice Mining Ltd 3.57 -40% $1,461,712,611
CXM Centrex Limited 0.075 -40% $47,321,993
KNO Knosys Limited 0.036 -40% $8,645,548
MTB Mount Burgess Mining 0.003 -40% $3,046,940
PKD Parkd Ltd 0.018 -40% $2,036,367
RCR Rincon 0.033 -40% $2,221,804
TG1 Techgen Metals Ltd 0.036 -40% $3,009,563
BC8 Black Cat Syndicate 0.23 -39% $60,047,202
RAC Race Oncology Ltd 0.8 -39% $132,901,056
RVS Revasum 0.135 -39% $14,828,332
KCC Kincora Copper 0.041 -39% $6,600,437
PNR Pantoro Limited 0.049 -39% $265,405,556
GLE GLG Corp Ltd 0.135 -39% $10,003,500
OMX Orange Minerals 0.032 -38% $1,589,356
KNG Kingsland Minerals 0.185 -38% $7,602,366
SKF Skyfii Ltd 0.042 -38% $18,466,279
AIS Aeris Resources Ltd 0.235 -38% $162,372,215
ZLD Zelira Therapeutics 1.07 -38% $12,481,871
CY5 Cygnus Metals Ltd 0.2 -38% $52,487,819
EEL Enrg Elements Ltd 0.005 -38% $6,059,790
IRE IRESS Limited 6.46 -37% $1,217,867,370
ABE Australian Bond Exchange 0.11 -37% $3,720,298
ALV Alvomin 0.17 -37% $13,004,340
POD Podium Minerals 0.041 -37% $14,573,464
TMB Tambourah Metals 0.215 -37% $17,417,474
Wordpress Table Plugin

 

On the losers list in August was biotech Mesoblast (ASX:MSB) which tanked more than 50% on August 4 after failing to receive US FDA approval for its stem cell treatment, remestemcel-L.

MSB announced the US FDA had provided a complete response to its Biologics License Application (BLA) resubmission for remestemcel-L for the treatment of paediatric steroid-refractory acute graft versus host disease (SR-aGVHD) and will require more data to support marketing approval.